Angela L. Cottrell

Angie is a seasoned transactional lawyer whose practice focuses on complex healthcare matters and navigating mergers and acquisitions.

She has advised and represented a wide variety of clients in financing transactions, healthcare regulatory matters, joint ventures, commercial contracts, clinical trials, corporate governance and more with the knowledge and insight only 25 years of experience can provide.

Prior to joining Smith Hulsey & Busey, Angie was a partner at a global AmLaw 100 firm in Raleigh, North Carolina. She also served as public finance counsel for the North Carolina State Treasurer, drafting legislation and advising legislative committees regarding various public finance projects.

Clients value Angie’s ability to quickly comprehend what they want to accomplish in their deals. As a former commercial lender with her MBA degree, Angie’s pre-law background influences how she tackles deals: she applies a practical, business-focused approach to her practice.

Angie understands transactions can be time-sensitive and that an attorney’s responsiveness is critical to the success of a deal. Her attentiveness and organizational skills enable her to successfully manage multiple transactions simultaneously. Although a significant portion of Angie’s M&A deals have been in healthcare, she has experience completing transactions across various industries, such as private equity and technology.

A true Floridian, Angie adores the beach and living by the water. In her free time, she enjoys the outdoors with her family, boating, fishing or paddle boarding. She also is an avid traveler, always on the lookout for opportunities to explore new places and meet new people.

Representative Matters

• Representing a public company in connection with various mergers, acquisitions and joint ventures.

• Representing a pharmaceutical company in a financing transaction with a major supplier.

• Representing a pharmaceutical company in its sale to a public company.

• Representing a large hospital system with respect to numerous hospital and physician acquisitions.

• Representing an emerging medical device company in a financing transaction and providing counsel on licensing issues and strategy with respect to clinical trials.

• Representing a large nonprofit healthcare system in public offerings of tax-exempt bonds and bond compliance.